Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5′ lone terminal repeat during oncogenesis

Journal of Virology

Volumn 81, Issue 11, 2007, Pages 5714-5723

  Miyazaki, Maki ^a   Yasunaga, Jun Ichirou ^a   Taniguchi, Yuko ^a   Tamiya, Sadahiro ^a   Nakahata, Tatsutoshi ^b   Matsuoka, Masao ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P30; REX PROTEIN; TAX PROTEIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENVELOPE GENE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; LONG TERMINAL REPEAT; NUCLEOTIDE SEQUENCE; P30 GENE; PRIORITY JOURNAL; PROVIRUS; QUANTITATIVE ANALYSIS; REX GENE; STRUCTURAL GENE; TAX GENE; VIRUS GENE;

AMINO ACID SEQUENCE; BASE SEQUENCE; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE, TUMOR; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MOLECULAR SEQUENCE DATA; PROVIRUSES; TERMINAL REPEAT SEQUENCES; VIRAL PROTEINS; VIRUS INTEGRATION;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 34249776954     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02511-06     Document Type: Article

References (56)

1. I is required for efficient viral infectivity in primary lymphocytes. J. Virol. 74:9828-9835.
2. Albrecht, B., and M. D. Lairmore. 2002. Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol. Mol. Biol. Rev. 66:396-406.
3. Arisawa, K., M. Soda, S. Endo, K. Kurokawa, S. Katamine, I. Shimokawa, T. Koba, T. Takahashi, H. Saito, H. Doi, and S. Shirahama. 2000. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int. J. Cancer 85:319-324.
4. Arnold, J., B. Yamamoto, M. Li, A. J. Phipps, I. Younis, M. D. Lairmore, and P. L. Green. 2006. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 107:3976-3982.
5. Asante-Appiah, E., and A. M. Skalka. 1997. Molecular mechanisms in retrovirus DNA integration. Antivir. Res. 36:139-156.
6. Bangham, C. R. 2003. Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control. Int. J. Hematol. 78:297-303.
7. Basbous, J., C. Arpin, G. Gaudray, M. Piechaczyk, C. Devaux, and J. M. Mesnard. 2003. The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J. Biol. Chem. 278:43620-43627.
8. Cavanagh, M. H., S. Landry, B. Audet, C. Arpin-Andre, P. Hivin, M. E. Pare, J. Thete, E. Wattel, S. J. Marriott, J. M. Mesnard, and B. Barbeau. 2006. HTLV-I antisense transcripts initiating in the 3′ LTR are alternatively spliced and polyadenylated. Retrovirology 3:15.
9. Cullen, B. R., P. T. Lomedico, and G. Ju. 1984. Transcriptional interference in avian retroviruses - implications for the promoter insertion model of leukaemogenesis. Nature 307:241-245.
10. I expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells. J. Virol. 76:10374-10382.
11. I: association with calreticulin and calnexin. J. Virol. 75:7672-7682.
12. Doi, K., X. Wu, Y. Taniguchi, J. Yasunaga, Y. Satou, A. Okayama, K. Nosaka, and M. Matsuoka. 2005. Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states. Blood 106:1048-1053.
13. Etoh, K., S. Tamiya, K. Yamaguchi, A. Okayama, H. Tsubouchi, T. Ideta, N. Mueller, K. Takatsuki, and M. Matsuoka. 1997. Persistent clonal proliferation of human T-lymphotropic virus type 1-infected cells in vivo. Cancer Res. 57:4862-4867.
14. Fan, H., M. Palmarini, and J. C. DeMartini. 2003. Transformation and oncogenesis by jaagsiekte sheep retrovirus. Curr. Top. Microbiol. Immunol. 275:139-177.
15. Franchini, G., R. Fukumoto, and J. R. Fullen. 2003. T-cell control by human T-cell leukemia/lymphoma virus type 1. Int. J. Hematol. 78:280-296.
16. Fung, Y. K., A. M. Fadly, L. B. Crittenden, and H. J. Kung. 1981. On the mechanism of retrovirus-induced avian lymphoid leukosis: deletion and integration of the proviruses. Proc. Natl. Acad. Sci. USA 78:3418-3422.
17. Furukawa, Y., R. Kubota, M. Tara, S. Izumo, and M. Osame. 2001. Existence of escape mutant in HTLV-1 tax during the development of adult T-cell leukemia. Blood 97:987-993.
18. Gallo, R. C. 2002. Human retroviruses after 20 years: a perspective from the past and prospects for their future control. Immunol. Rev. 185:236-265.
19. Gaur, M., and A. D. Leavitt. 1998. Mutations in the human immunodeficiency virus type 1 integrase D,D(35)E motif do not eliminate provirus formation. J. Virol. 72:4678-4685.
20. Goff, S. 2001. Retroviridae: the retroviruses and their replication, p. 1871-1939. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
21. Grassmann, R., M. Aboud, and K. T. Jeang. 2005. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24:5976-5985.
22. Grossman, W. J., J. T. Kimata, F. H. Wong, M. Zutter, T. J. Ley, and L. Ratner. 1995. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 92:1057-1061.
23. Hasegawa, H., H. Sawa, M. J. Lewis, Y. Orba, N. Sheehy, Y. Yamamoto, T. Ichinohe, Y. Tsunetsugu-Yokota, H. Katano, H. Takahashi, J. Matsuda, T. Sata, T. Kurata, K. Nagashima, and W. W. Hall. 2006. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 12:466-472.
24. Hayward, W. S., B. G. Neel, and S. M. Astrin. 1981. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290:475-480.
25. Inoue, J., M. Yoshida, and M. Seiki. 1987. Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. Proc. Natl. Acad. Sci. USA 84:3653-3657.
26. Jin, D. Y., F. Spencer, and K.T. Jeang. 1998. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93:81-91.
27. Kikuchi, K., H. Ikeda, T. Tsuchikawa, T. Tsuji, S. Tanaka, K. Fugo, T. Sugaya, Y. Tanaka, M. Tateno, N. Maruyama, and T. Yoshiki. 2002. A novel animal model of thymic tumour: development of epithelial thymoma in transgenic rats carrying human T lymphocyte virus type I pX gene. Int. J. Exp. Pathol. 83:247-255.
28. I functions to modulate nuclear factor of activated T cell activation. J. Biol. Chem. 278:15550-15557.
29. Koiwa, T., A. Hamano-Usami, T. Ishida, A. Okayama, K. Yamaguchi, S. Kamihira, and T. Watanabe. 2002. 5′-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J. Virol. 76:9389-9397.
30. Kuo, Y. L., and C. Z. Giam. 2006. Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence. EMBO J. 25:1741-1752.
31. Matsuoka, M. 2005. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2:27.
32. Matsuoka, M., and K. T. Jeang. 2005. Human T-cell leukemia virus type I at age 25: a progress report. Cancer Res. 65:4467-4470.
33. II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology 1:39.
34. Munger, K., A. Baldwin, K. M. Edwards, H. Hayakawa, C. L. Nguyen, M. Owens, M. Grace, and K. Huh. 2004. Mechanisms of human papillomavirus- induced oncogenesis. J. Virol. 78:11451-11460.
35. Murata, K., T. Hayashibara, K. Sugahara, A. Uemura, T. Yamaguchi, H. Harasawa, H. Hasegawa, K. Tsuruda, T. Okazaki, T. Koji, T. Miyanishi, Y. Yamada, and S. Kamihira. 2006. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J. Virol. 80:2495-2505.
36. Neel, B. G., W. S. Hayward, H. L. Robinson, J. Fang, and S. M. Astrin. 1981. Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion. Cell 23:323-334.
37. Nevins, J. 2001. Cell transformation by viruses, p. 245-283. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed., vol. 1. Lippincott Williams & Wilkins, Philadelphia, PA.
38. II is a post-transcriptional negative regulator of viral replication. Nat. Med. 10:197-201.
39. Nicot, C., R. L. Harrod, V. Ciminale, and G. Franchini. 2005. Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Oncogene 24:6026-6034.
40. Ohshima, K., A. Ohgami, M. Matsuoka, K. Etoh, A. Utsunomiya, T. Makino, M. Ishiguro, J. Suzumiya, and M. Kikuchi. 1998. Random integration of HTLV-1 provirus: increasing chromosomal instability. Cancer Lett. 132:203-212.
41. Payne, G. S., S. A. Courtneidge, L. B. Crittenden, A. M. Fadly, J. M. Bishop, and H. E. Varmus. 1981. Analysis of avian leukosis virus DNA and RNA in bursal tumours: viral gene expression is not required for maintenance of the tumor state. Cell 23:311-322.
42. Peloponese, J. M., Jr., K. Haller, A. Miyazato, and K. T. Jeang. 2005. Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc. Natl. Acad. Sci. USA 102:18974-18979.
43. Pique, C., A. Ureta-Vidal, A. Gessain, B. Chancerel, O. Gout, R. Tamouza, F. Agis, and M. C. Dokhelar. 2000. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J. Exp. Med. 191: 567-572.
44. Satou, Y., J. Yasunaga, M. Yoshida, and M. Matsuoka. 2006. HTLV-1 basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl. Acad. Sci. USA 103:720-725.
45. Seiki, M., R. Eddy, T. B. Shows, and M. Yoshida. 1984. Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells. Nature 309:640-642.
46. Seiki, M., S. Hattori, Y. Hirayama, and M. Yoshida. 1983. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA 80:3618-3622.
47. Shimoyama, M. 1991. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br. J. Haematol. 79:428-437.
48. Shuh, M., S. A. Hill, and D. Derse. 1999. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses. Virology 262:442-451.
49. II is required for in vivo replication: evidence of in vivo reversion. J. Virol. 78:3837-3845.
50. Stary, A., and A. Sarasin. 1992. Molecular analysis of DNA junctions produced by illegitimate recombination in human cells. Nucleic Acids Res. 20:4269-4274.
51. Stehelin, D., H. E. Varmus, J. M. Bishop, and P. K. Vogt. 1976. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260:170-173.
52. Takeda, S., M. Maeda, S. Morikawa, Y. Taniguchi, J. Yasunaga, K. Nosaka, Y. Tanaka, and M. Matsuoka. 2004. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int. J. Cancer 109:559-567.
53. Tamiya, S., M. Matsuoka, K. Etoh, T. Watanabe, S. Kamihira, K. Yamaguchi, and K. Takatsuki. 1996. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood 88:3065-3073.
54. Taniguchi, Y., K. Nosaka, J. Yasunaga, M. Maeda, N. Mueller, A. Okayama, and M. Matsuoka. 2005. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2:64.
55. Yoshida, M. 2001. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 19:475-496.
56. II regulates gene transcription by binding CREB binding protein/p300. J. Virol. 75:9885-9895.